Biosense Webster Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Biosense Webster's estimated annual revenue is currently $1.7B per year.(i)
  • Biosense Webster's estimated revenue per employee is $251,000

Employee Data

  • Biosense Webster has 6669 Employees.(i)

Biosense Webster's People

NameTitleEmail/Phone
1
Area VP SalesReveal Email/Phone
2
Executive Admin to VP Human ResourcesReveal Email/Phone
3
Executive Assistant to VP R&DReveal Email/Phone
4
VP Quality & ComplianceReveal Email/Phone
5
Director, Global Clinical OperationsReveal Email/Phone
6
Director Medical AffairsReveal Email/Phone
7
Sr. Director, Strategic PartnershipsReveal Email/Phone
8
DirectorReveal Email/Phone
9
Regional Business DirectorReveal Email/Phone
10
Regional Business DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$11470M536044%$6.3B$63.9B
Add Company

What Is Biosense Webster?

Biosense Webster is recognized worldwide as a leader in the science behind the diagnosis and treatment of cardiac arrhythmias.The first useful deflectable tip catheter was pioneered by Will Webster more than three decades ago. Ever since, Biosense Webster has defined the state of design and craftsmanship in diagnostic and therapeutic cardiac catheters. In fact, we offer more electrophysiology catheter designs than anyone else in the industry. But beyond numbers, our continuous pursuit of practical innovation has led to a steady flow of breakthrough designs.

keywords:N/A

N/A

Total Funding

6669

Number of Employees

$1.7B

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Biosense Webster News

2022-04-20 - Atrial Fibrillation Market Competitive Insights and ...

Biosense Webster, Inc. CardioFocus, Inc. CathEffects Inc. – themobility.club...

2022-04-19 - Electrophysiology Market Size, Scope And Outlook | Abbott ...

Abbott Laboratories (U.S.), Biosense Webster, Inc. (U.S.), BIOTRONIK SE & Co. KG (Germany), Boston Scientific Corporation (U.S.),...

2022-04-17 - 18 of the world's most innovative medical technologies | MDO

Carto Prime is a 3D mapping technology for cardiac imaging developed by Johnson & Johnson's subsidiary Biosense Webster.

2011-01-04 - Roth Capital upgrades AtriCure stock

Investment bank Roth Capital Partners upgraded shares of AtriCure Inc. (NSDQ:ATRC) to “Buy” and raised its target price by nearly 30 percent. AtriCure, a cardiac surgical device maker, will enter “a new phase” during the next two years in which its growth rate will improve, according to a new r ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2549.6M67457%N/A
#2
$2365.8M69545%N/A
#3
$2071.6M7218-2%N/A
#4
$1544.8M110344%N/A
#5
$4751.8M125718%N/A